A decision by the U.S. Patent and Trademark Office appears to set back a claim by the National Institutes of Health covering test kits for acquired immune deficiency syndrome. In a statement on rival patents filed by the U.S. group and France s Pasteur Institute, the agency granted senior party status to the French lab